About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Prediabetes Intervention With Tea | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT05583045

Prediabetes Intervention With Tea

The goal of this interventional study is investigating the effect of the daily consumption of olive leaves tea on glycemic control of individuals diagnosed with pre-diabetes. The hypothesis of this st...

Lead sponsor: Instituto Politécnico de Bragança•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Instituto Politécnico de Bragança

Collaborators

Unidade Local de Saude do Nordeste
European Social Fund

This study is a triple-blinded, randomized, placebo-controlled trial with parallel assignment

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•At least one of three glycemic criteria for pre diabetes as defined by 2022 American Diabetes Association (ADA) guidelines:
•Fasting plasma glucose level, 100 to 125 mg per deciliter (5.6 to 6.9 mml per liter);
•Plasma glucose level 2 hours after a 75-g oral glucose load, 140 to 199 mg per deciliter (7.8 to 11.0 mml per liter);
•Glycated hemoglobin level, 5.7 to 6.4% (39 to 47 mml per mole).

Exclusion Criteria

•Current use of medication for lowering blood cholesterol, glucose or hypertension;
•History of chronic or severe diseases that may affect study outcomes or limit study participation;
•Pregnancy and breastfeeding

Related studies

RECRUITINGPhase 1

A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

NCT07590193 · Diabetes Mellitus, Type 2

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more

Collection of Human Metabolic Tissues

NCT02861781 · Obesity, Insulin Resistance, and more

Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus

NCT05692388 · Diabetic Nephropathy Type 2 - Uncontrolled, Diabetes Mellitus, Type 2, and more

Milk for Diabetes Prevention

NCT06513026 · Lactose Intolerance, Lactose Intolerant, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 19, 2022Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment140

Start dateNov 2022

Last updatedOct 19, 2022

Condition

Diabetes Mellitus, Type 2 Pre Diabetes

Locations shown

Instituto Politécnico de Bragança

Bragança

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 19, 2022Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions